News

liver cancer

The completion of the first treatment represents a "significant milestone" for patients with liver cancer, the IR who led the procedure says.

cybersecurity

Is the edge with the cybercriminals looking for weak points in firewalls? Or the security professionals trying to stop the bad guys from finding any? 

cannabis weed marijuana heart health doctor cardiologist

The Centers for Medicare & Medicaid Services unveiled a new program for alternative payment model participants that would allow clinicians to use products containing CBD as part of patient care plans. In response, the Food and Drug Administration vowed not to further restrict the sale of oral hemp products.

Steve MacMillan Hologic

The Marlborough, Massachusetts-based breast imaging vendor expects its sale to TPG and Blackstone to officially close on April 7. 

mammography mammogram breast imaging

“Radiology practices may wish to consider these findings when presenting patients with an option to pay for AI interpretation,” experts write in JACR

Leaders at the hospital have equipped the radiology department’s MRI scanner with a new AI software that essentially fills in the blanks between image slices with synthetic images.

Medicare Money

CMS officially announced the move on April 6, with it applying to the Wasteful and Inappropriate Service Reduction (WISeR) Model. 

Thumbnail

Therapy-related acute myeloid leukemia is an aggressive form of blood cancer and bone marrow that occurs in the years following radiation and chemotherapy. 

Aakriti Gupta, MD, Cedars-Sinai, explains use of cerebral embolic protection devices in TAVR

Cardiologist Aakriti Gupta, MD, MSc, spoke to Cardiovascular Business about the latest data and trends associated with using cerebral embolic protection devices during TAVR to lower the risk of stroke.

Heartflow artificial intelligence CCTA images

The company's AI-powered CCTA assessments have already been used to help manage more than 400,000 heart patients around the world.

Thumbnail

Maricopa County, Arizona, resident Rosemary Hamermaster and others are seeking a jury trial and damages of more than $5 million. 

ezra

The New York-based healthcare AI firm has scored U.S. Food and Drug Administration clearance for its Ezra Flash, a class 2 medical device. 

Around the web

The completion of the first treatment represents a "significant milestone" for patients with liver cancer, the IR who led the procedure says.